Dattatraya Medical & General Stores

Country/Region: India     State/Province: New Delhi

Main Products: TRANSTUZUMAB, RITUXIMAB, PEGFILGRASTIN, NIMOTUZUMAB, FULVESTRANT, TRANSTUZUMAB

Company Introduction
With years of affluent industry expertise and experience, DATTATRAYA MEDICAL & GENERAL STORES Pvt Ltd takes pride in providing an extensive range of Amphotericin B Injection along with TRANSTUZUMAB,RITUXIMAB,PEGFILGRASTIN,NIMOTUZUMAB,FULVESTRANT. Our Amphotericin B Injection is quality assured and comply with international industry standards which is very important to us owing to the international export market share including Germany,Pakistan,Turkey,United States,Vietnam. Buyers can expect superior grade pieces, reliability and admirable specifications in price, having no match. It helped us expand our consumer base and in no time we reached Approx 0.8 Million US Dollar worth of annual revenue.The high-tech storage facility and an ultramodern inventory management system launched with initial business capital of US$50 Million - US$100 Million and sufficient production capacity caters to US$2.5 Million - US$5 Million of export value, keeping the consumer reliability in check. Dattatraya Medical & General Stores is a located in New Delhi, , India operating under Third Party, but boast a vast distribution network, it has always been easy for us to deliver bulk and retail orders. Being a reputable Manufacturer and Supplier of [keywords] since 2008, we have been successfully delivering to customers holding 12 Years of export history.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2008, 2008

Legal Status: Third Party

Ownership: Pvt Ltd

Employees: Above 1000 People

Factory Size: 10, 000-30, 000 square meters

R&D Team Size: 51 - 100 People

Certifications: ISO14001

Contact Information

Contact Person: Mr. Dilip JANE

Designation: Marketing

Department: Export Department

Telephone: 919822711621

Business Information

Main Markets: Germany (30%) Pakistan (29%) Turkey (28%) United States (19%) Vietnam (15%)

Export Focus: Germany, Pakistan, Turkey, United States, Vietnam

Contract Services: Design Service Offered

Trade & Financial Information

Annual Revenue: Approx 0.8 Million US Dollar

Registered Capital: US$50 Million - US$100 Million

Export Percentage: 61% - 70%

Payment Terms: Bank wire (T/T)

Product Showcase
TRANSTUZUMAB
RITUXIMAB
PEGFILGRASTIN
NIMOTUZUMAB
FULVESTRANT
TRANSTUZUMAB
RITUXIMAB
PEGFILGRASTIN
NIMOTUZUMAB
FULVESTRANT

CL-Link > Health & Medicines in India Health & Medicines in New Delhi Medicines in India Medicines in New Delhi